Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life studyPiero Barbanti, Fabrizio Vernieri, Cinzia Aurilia et al.|Headache The Journal of Head and Face Pain|2020Cited by 129
Evidence-based guidelines for the pharmacological treatment of migraineRaffaele Ornello, Ilaria Orologio, Anna Ambrosini et al.|Cephalalgia|2025Cited by 44